|
Status |
Public on Feb 12, 2020 |
Title |
SC68_cr.LB19003 |
Sample type |
SRA |
|
|
Source name |
MDA-SC68_cr
|
Organism |
Homo sapiens |
Characteristics |
tissue: CDX flank patient diagnosis: small cell lung cancer (SCLC) treatment: cisplatin, relapsed
|
Treatment protocol |
Mice were untreated
|
Growth protocol |
Tumors were grown in mice to between 500-800 mm3
|
Extracted molecule |
total RNA |
Extraction protocol |
Tumors were collected and RNA extracted using Trizol reagent and purified with a Qiagen RNeasy kit Sequencing library were constructed following 10x Genomics Chromiun v2 library preparation protocol.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2000 |
|
|
Description |
none
|
Data processing |
Seqeuncing reads were processed using Cell Ranger v2.0 pipeline (10x Genomics) Genome_build: hg38 Supplementary_files_format_and_content: UMI reads count were calculated by Cell Ranger v2.0
|
|
|
Submission date |
Oct 01, 2019 |
Last update date |
Oct 23, 2020 |
Contact name |
Yuanxin Xi |
E-mail(s) |
xiyuanxin@yahoo.com
|
Phone |
530-220-2067
|
Organization name |
The University of Texas MD Anderson Cancer Center
|
Department |
Bioinformatics and Computational Biology
|
Street address |
1400 Pressler St
|
City |
Houston |
State/province |
TX |
ZIP/Postal code |
77030 |
Country |
USA |
|
|
Platform ID |
GPL11154 |
Series (2) |
GSE138267 |
Single-cell analyses reveal increasing intratumoral heterogeneity as an essential component of treatment resistance in small cell lung cancer [RNA-Seq] |
GSE138474 |
Single-cell analyses reveal increasing intratumoral heterogeneity as an essential component of treatment resistance in small cell lung cancer |
|
Relations |
BioSample |
SAMN12881016 |
SRA |
SRX6931281 |